SIE-1
ROV-SIE-2025-01
Phase 1 other active
Quick answer
SIE-1 for Hormone receptor-positive early breast cancer in post-menopausal women is a Phase 1 program (other) at Laboratorios Tillomed Spain S.L.U with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Laboratorios Tillomed Spain S.L.U
- Indication
- Hormone receptor-positive early breast cancer in post-menopausal women
- Phase
- Phase 1
- Modality
- other
- Status
- active